Market Overview

UPDATE: Goldman Sachs Upgrades Zimmer Holdings to Neutral on Improving Orthopedic Volumes

Share:
Related ZMH
Benzinga's Top Upgrades
Jefferies Upgrades Zimmer Holdings To Buy

Goldman Sachs raised its rating on Zimmer Holdings (NYSE: ZMH) from Sell to Neutral and increased its price target from $58 to $70.

Goldman Sachs noted, "Our investment thesis is based on the following factors: (1) improving outlook on US orthopaedic surgical volumes; (2) decelerating rates of pricing pressure; (3) capital allocation optionality with the potential for larger free cash flow returns to shareholders; and (4) shares appear fairly valued at current levels. Since being added to the Americas Sell List on August 9, 2011, ZMH shares are up 20.5% vs. the S&P 500 up 21.0%. On a trailing 12-month basis, ZMH is +33.0% vs. the S&P 500 +13.0%."

Zimmer Holdings closed at $65.50 on Monday.

Latest Ratings for ZMH

DateFirmActionFromTo
Feb 2015Argus ResearchMaintainsBuy
Feb 2015JefferiesUpgradesBuy
Feb 2015Deutsche BankMaintainsHold

View More Analyst Ratings for ZMH
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Upgrades Intraday Update Analyst Ratings

 

Related Articles (ZMH)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→